OBJECTIVES: Despite progress in management, mitral valve endocarditis (MVE) is still a life-threatening disease. We report our experience in surgical treatment of infective isolated MVE.
INTRODUCTION
Mitral valve infective endocarditis (IE) is still associated with considerable morbidity and mortality, despite the use of more effective antimicrobial agents, better diagnostic tools and improved medical and surgical management [1, 2] . The reported complication rate is significantly higher for prosthetic mitral valve endocarditis (MVE) compared with native valve endocarditis (NVE) [3, 4] .
Surgery is indicated in severe mitral valve regurgitation with or without congestive heart failure, uncontrolled sepsis, mitral annular abscess, multiple emboli and large vegetation(s) [5] . Mitral valve repair is the preferred treatment for native endocarditis in our and many other institutions and may be attempted if there is sufficient remaining tissue to allow valve reconstruction without tensions [6, 7] . Repair is reported to be feasible in up to 80% of patients with mitral NVE [8] . The possibility to intervene with low operative risk and to avoid or minimize the implantation of prosthetic material is attractive, but in case of extensive destruction of the mitral leaflets, annulus and/or the subannular apparatus, replacement with a prosthetic mitral valve is unavoidable [9] .
The aim of this study was to collate our single-centre experience of surgical treatment in patients with isolated MVE over a 16-year period. We reported mortality and morbidity after the surgical intervention and identified preoperative variables with independent association to late mortality.
PATIENTS AND METHODS

Patients
All patients operated for isolated MVE at Sahlgrenska University Hospital between January 2000 and December 2015 were included in a retrospective observational study. The patients were identified in the SWEDEHEART registry, where data on all patients who undergo cardiac surgery in Sweden are registered [10] . Additional data were collected from institutional databases and patient records. The regional research ethics committee approved the study and waived individual patient consent. The diagnosis of IE was based on the results of echocardiography and blood cultures [11] .
Surgical technique
Indication for surgical intervention followed current international recommendations, which changed marginally during the study period [5, 11] . The decision regarding surgical treatment in an individual patient was made jointly by a senior surgeon and the responsible infectious disease specialist. The operations were performed with cardiopulmonary bypass and moderate hypothermia. All interventions were performed through a median sternotomy. A standard cannulation was performed in the ascending aorta, while a bicaval cannulation or a single cannula in right atrium was used for the venous cannulation. Cold (4 C) intermittent antegrade blood cardioplegia was used for myocardial protection. The mitral valve was exposed using a paraseptal or trans-septal incision. The valve and surrounding tissue were carefully inspected. In patients with mitral NVE, repair was performed when possible. When the mitral valve was severely damaged, the valve was replaced with a prosthesis. In patients who had undergone previous mitral valve repair, a new repair procedure was performed whenever possible. In patients with mitral prosthetic MVE, the prosthesis was replaced with a new mechanical or biological prosthetic valve. The implantation of the prosthetic valves was performed using standard techniques. When the infection had extended into the annulus and the surrounding tissue, the valve was excised, and all infected and necrotic tissues were radically and aggressively resected. Reconstruction of the mitral annulus was performed with a patch of pericardium, and then, the valve was replaced [12] .
Registered variables
Preoperative, perioperative and postoperative variables were registered prospectively in an institutional database. Patient clinical records were reviewed to confirm all data. The variables are listed in Table 1 . Deaths beyond the immediate postoperative period were collected from the Swedish Population Registry. Mean follow-up was 68 months (range 1-168 months) and 100% complete. The last day of follow-up was 16 March 2016.
Definitions
Prosthetic MVE was defined as an episode of endocarditis involving a prosthetic mitral valve, mechanical or biological, or an infection affecting a mitral valve on which a previous valve repair had been performed. Mitral NVE was defined as an infection involving the mitral valve on which an operation had not been performed. Severe postoperative complications were defined as renal failure requiring dialysis, perioperative stroke, atrioventricular block requiring pacemaker implantation, perioperative myocardial infarction based on enzymes and electrocardiographic signs, need for prolonged mechanical ventilation requiring tracheotomy and heart failure, which is defined as the need for inotropic support drugs for more than 24 h or the use of an intra-aortic balloon pump or left ventricular assistance device. Reoperation during follow-up was defined as any new cardiothoracic operation.
Statistical analysis
Cumulative long-term survival was calculated with the KaplanMeier method. Cox regression was used to identify factors associated with mortality during follow-up. The model was developed by first removing highly correlated variables, followed by univariable testing and then variables with a P-value of <0.20 were kept to allow potential confounders. Finally, all the remaining variables were included in a multivariable model, where variables with a P-value of >0.15 or not being confounders (i.e. having an effect size change of any other parameter more than 15%) were removed. The proportional hazards assumption of the categorical covariates in the multiple model was checked by log-log plots. The lines were acceptable parallel considering the sample size. In addition, a hypothesis test based on the Schoenfeld residuals to check proportionality was performed [13] . None of the remaining variables in the model had a P-value <0.3. Hence, there were no indications that the proportional hazards assumptions were violated. Logistic regression was used to identify factors associated 
RESULTS
Patient characteristics
Hundred and forty consecutive operations for MVE were performed in 128 patients. Eight patients had 2 episodes of IE requiring surgery and 2 patients had 3 episodes of endocarditis requiring surgery. Median age was 60 (range 51-69) years, and 100 (71%) patients were men. Patient characteristics are listed in Table 1 . One-hundred and nine (78%) operations were performed in patients with IE on a native mitral valve, whereas 31 (22%) operations were performed in patients with IE on a prosthetic mitral valve (n = 15) or after a previous surgical mitral valve repair (n = 16). Three (2%) operations were performed in patients with a previous cardiac operation that did not involve the mitral valve.
Periannular abscess formation was diagnosed in 23 (16%) operations, and vegetation(s) was present at 95 (68%) operations. Seventy-seven (55%) operations were performed in patients with severe concomitant diseases at hospital admission (Table 1) .
Procedures for endocarditis
Seventy-six (54%) operations were isolated mitral valve repair, while sixty-four (46%) operations were isolated valve replacements with either a biological prosthesis (n = 36, 56%) or a mechanical prosthesis (n = 28, 44%). In thirty (21%) operations, concomitant cardiac surgery was performed (Table 2) . Three operations included aortic valve replacement for an aortic valve disease not related to IE. In 4 operations in patients with suspected concomitant aortic valve endocarditis, the aortic valve was inspected through an aortotomy but no aortic procedure was performed.
Perioperative complications
One or more severe perioperative complications as defined above occurred after 59 operations ( Table 2 ). The median length of stay in the intensive care unit after the operation was 2 (range 2-5) days and median total length of stay in the cardiothoracic clinic was 9 (range 7-14) days (Table 2) . After this period, the patients were transferred to a clinic for infectious medicine for antibiotic treatment.
Early mortality
There was 13 deaths within 30 days after the 140 operations (9%); 6 patients died of multiorgan failure, 3 patients of heart failure, 3 patients of neurological complications and 1 patient due to rupture of the abdominal aorta.
The preoperative variables that were significantly associated with early mortality in univariable testing were age, chronic obstructive disease, EuroSCORE II, perivalvular abscess, circulatory support before surgery and prosthetic valve endocarditis. Furthermore, extracorporeal circulation time, peak postoperative serum creatinine, postoperative respiratory failure, new stroke, postoperative heart failure and reoperation for bleeding had an association with early mortality (Supplementary Material, Table S1 ).
Microbiological features
The infective aetiology was diagnosed preoperatively by blood culture in 126 of 140 (90%) operations. Bacteria belonging to the Staphylococcus and Streptococcus families were the most common agents (42% and 36%, respectively) ( Table 2) . Among the 13 patients who died within 30 days, 7 (54%) patients had a staphylococcus infection and 2 (15%) patients had a streptococcus infection.
Long-term survival
In total, there were 42 deaths during the follow-up period corresponding to 5.3 deaths per 100 patient-years. Cumulative survival in the whole patient population was 73 ± 4% at 5 years and 62 ± 5% at 10 years (Fig. 1) . Variables with a univariable association with mortality during the whole follow-up period were age, chronic obstructive pulmonary disease, diabetes, EuroSCORE II, preoperative serum creatinine, sepsis, dialysis, perivalvular abscess, mitral valve replacement, extracorporeal circulation time, aortic cross-clamp time, staphylococci infection, and peak postoperative serum creatinine as well as postoperative respiratory failure, new stroke and heart failure ( Table 3 ; Supplementary Material, Table S2 ).
Preoperative variables significantly associated with overall mortality in the final multiple Cox regression model were age, chronic obstructive pulmonary disease and EuroSCORE II.
Valve repair was performed in 76 (54%) operations and replacement in 64 (46%) operations. Thirty-day mortality for repair was 1%, and 5-year and 10-year cumulative survival was 86 ± 4% and 77 ± 6%, respectively (Fig. 2) . For replacement, 30-day mortality was 19%, and cumulative survival at 5 years and 10 years was 55 ± 7% and 41 ± 8%, respectively. Postoperative complications occurred in 21% and 67%, respectively.
Thirty-day mortality after the first operation for mitral endocarditis was 12% and 38%, respectively, in patients with native and prosthetic endocarditis.
Operative procedures
Seventy-six (54%) operations were mitral valve repairs and 64 (46%) were valve replacements. Characteristics of repair and replacement surgery are presented in Tables 1 and 2 . Generally, patients with mitral replacement had more complex disease and more perioperative complications. Thirty-day mortality for repair was 1%, and 5-year and 10-year cumulative survival was 86 ± 4% and 77 ± 6%, respectively (Fig. 2) . For replacement, 30-day mortality was 19%, and cumulative survival at 5 years and 10 years was 55 ± 7% and 41 ± 8%, respectively (Fig. 2) . Postoperative complications occurred in 21% and 67%, respectively, for repair and replacement.
Recurrence
There were 12 reoperations for recurrent endocarditis (9%) in 10 patients during the study period. Eight patients underwent 1 reoperation for endocarditis and 2 patients had 2 reoperations. In these 12 reoperations, 4 operations were performed in patients with a biological valve. The infected valve was replaced with a biological (n = 1) or a mechanical valve (n = 3). Eight patients have had an earlier valve repair, and the valve was repaired at reoperation in 3 patients, replaced with a biological valve in 3 patients and a mechanical valve in 2 patients. Recurrence occurred within 3 months of the initial operation after 7 operations, from 3 to 12 months after 2 operations and after 12 months after 3 operations. Four patients had an additional episode of IE on a prosthetic valve and 8 patients after a valve repair. In this last group of patients, 5 were operated within 3 months from the initial operation, 1 within 3-12 months and 2 after 12 months. In 9 of the 12 reoperations for recurrent endocarditis, the same aetiological agent as in the first operation was identified (relapse). Reinfection occurred after 4 of 59 operations when there was a staphylococcal infection (7%) at the first operation and in 4 of 50 (8%) operations with streptococcal infection.
DISCUSSION
The main findings in this retrospective observational singlecentre study were (i) mitral valve repair in endocarditis can be performed in suitable patients with excellent results; (ii) patients who received a valve replacement had a high rate of comorbidity, a complex perioperative and postoperative outcome and high 30-day mortality, and (iii) age, diabetes and EuroSCORE II were preoperative factors independently associated with longterm survival.
Overall 30-day mortality after the 140 operations was 9%. These results are comparable or better than in most reports previously published on the subject [5, 11, 14] . In our population, the patients who received a mitral valve replacement generally had a higher risk profile and a more complex operation and postoperative course (Tables 1 and 2 ), which was reflected in a higher early mortality. It is difficult to compare the outcome of patients operated with mitral valve repair or mitral valve replacement for endocarditis because patient characteristics are so different. Specifically, the range of the extension of the infection, from minimal destruction of the leaflets to tissue destruction beyond the valve and into the paravalvular structures, with or without abscesses, differs between repair and replacement patients [15] . Interestingly, when deaths during the 1st postoperative year were excluded, the long-term mortality was comparable between repair and replacement patients (Fig. 2) . This indicates that the choice of method (repair or replacement) may be less deciding for long-term survival. This speculation is supported by a recent randomized trial in severe non-infectious mitral regurgitation patients, where survival was comparable between repair and replacement [16] . Instead, outcome in mitral endocarditis patients appears to be highly dependent on the extension of the infection in and around the mitral valve at the time of the operation, because the severity of the infection determines the operation method. However, it has been argued that the better outcome in patients with mitral valve repair is attributed also to the maintenance of anatomy and function of the native valve and the left ventricle [17] . In addition, avoidance of anticoagulation and a lower rate of recurrent endocarditis have been suggested to contribute to better outcome after repair [18, 19] .
Valve repair was performed in 54% of the operations in the present series. In published studies, the repair rate varies from 33% to 78% [14, [20] [21] [22] [23] [24] . The large range in repair rate may be explained by different levels of experience in mitral valve repair between centres and that surgery was performed at different stages of the disease. At advanced stages of the disease, with destruction of the leaflets and annulus, repair may be impossible.
In a meta-analysis by Feringa et al. [14] , the late recurrence rate was significantly lower after mitral valve repair compared with mitral valve replacement, (1.8% vs 7.3%, P = 0.0013). Valve repair in endocarditis patients may raise concerns, because an incomplete resection of infected tissue in case of extensive disease may increase the risk of relapse. Again, the feasibility and the safety of the repair procedure are directly related to the extensiveness of the infection. In this study, we did not observe a lower recurrence of reinfection after mitral valve repair compared with replacement (10.5% vs 6.3%). In our series, 5 of 8 repair patients with recurrent endocarditis were reoperated within 3 months after the primary operation. One may speculate that these relapses may be related to incomplete resection of the infected tissue.
Bacteria belonging to the staphylococcus and streptococcus families were the most common aetiological agents. This is in accordance with previous studies that have shown that staphylococci have replaced streptococci as the most common pathogen in IE [25, 26] . In our series, we did not find any significant difference in the distribution of bacteria of the staphylococcus or streptococcus family in the mitral valve repair and mitral valve replacement group.
Limitations
This study has important limitations. The patient population was limited and was collected over a long period. It is a retrospective study with a high risk of selection bias. This single-centre study was conducted in a tertiary care institution, resulting not only in limitations to generalization of the results but also to unavoidable referral bias. Also, there were no data on the duration of antibiotic therapy before surgery. The actual diagnostic features and indication for surgery in individual patients were not registered in our database. It was not possible to include a multivariable analysis on predictors for 30-day mortality due to the low number of events.
CONCLUSIONS
MVE requiring surgical treatment is a challenging disease with high hospital mortality when valve replacement is necessary. In contrast, outcome in patients suitable for repair is excellent. 
